Innate Pharma Stock Performance

Innate Pharma Relative Risk vs. Return Landscape

If you would invest  182.00  in Innate Pharma on November 20, 2025 and sell it today you would lose (13.00) from holding Innate Pharma or give up 7.14% of portfolio value over 90 days. Innate Pharma is currently does not generate positive expected returns and assumes 2.264% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Innate, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Innate Pharma is expected to under-perform the market. In addition to that, the company is 2.99 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.18 per unit of volatility.

Innate Pharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Innate Pharma has a beta of -0.0849. This usually indicates as returns on the benchmark increase, returns on holding Innate Pharma are expected to decrease at a much lower rate. During a bear market, however, Innate Pharma is likely to outperform the market. Additionally Innate Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Innate Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Innate Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.08 1.69 3.95 Details

Intrinsic Valuation Low Real High 0.39 2.65 4.91 Details

3 Analysts Consensus Low Target High 5.23 5.75 6.38 Details

Earnings Estimates (0) Low Projected EPS High -0.17 -0.15 -0.12 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Innate Pharma. Your research has to be compared to or analyzed against Innate Pharma's peers to derive any actionable benefits. When done correctly, Innate Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Innate Pharma.

Innate Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Innate Pharma is not an exception. The market had few large corrections towards the Innate Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Innate Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Innate Pharma within the framework of very fundamental risk indicators.

Innate Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Innate Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Innate Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Innate Pharma Price Density Drivers

Innate Pharma Fundamentals Growth

When running Innate Pharma's price analysis, check to measure Innate Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innate Pharma is operating at the current time. Most of Innate Pharma's value examination focuses on studying past and present price action to predict the probability of Innate Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innate Pharma's price. Additionally, you may evaluate how the addition of Innate Pharma to your portfolios can decrease your overall portfolio volatility.